[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591185":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":30,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":58},{"fullName":5,"class":6},"University of Luebeck","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Ingo Eitel, Prof. Dr.","CONTACT","+49 451 500 44501","cvro@uksh.de",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":7,"country":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"Universitätsklinikum Schleswig-Holstein","RECRUITING","Lübeck","Schleswig-Holstein","Germany",{"type":22,"coordinates":23},"Point",[24,25],10.68729,53.86893,{"lat":25,"lon":24},[28],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":29},"ingo.eitel@uksh.de",{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Prof. Dr. med. Ingo Eitel","Head of Department","100591185",false,"NCT06977139","Interventional Structural Registry - LuEbeck","INSTYLE","Inclusion Criteria:\n\n* Structural heart disease\n\nExclusion Criteria:\n\n* Patients without consent\u002Finformation\n* Age ≤ 18 years","ALL","18 Years",{"count":43,"type":44},2000,"ESTIMATED","OBSERVATIONAL","The aim of the registry is to investigate the effect of catheter-assisted procedures in the context of structural heart disease on clinical morbidity and mortality. Furthermore, the long-term prognosis of patients after a catheter-based procedure is to be evaluated.\n\nIn particular, the following parameters will be documented and the following questions discussed:\n\n* Underlying and concomitant diseases of these patients\n* Evaluation of the methods in relation to the respective disease\n* Safety - acute and long-term\n* Effectiveness - periprocedural, hospital and long-term course\n* Concomitant therapies",[48],"Structural Heart Disease","2025-05-08",{"date":51,"type":52},"2025-05-18","ACTUAL",{"date":54,"type":52},"2021-09-11",{"date":56,"type":44},"2035-01-01",{"name":32,"class":6},1]